Harpoon Therapeutics HARP

$ 23.01 0.0%

Quarterly report 2023-Q3
added 11-09-2023

Harpoon Therapeutics Financial Statements 2011-2024 | HARP

Annual Financial Statements Harpoon Therapeutics

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	21.6 M	171 M	483 M	293 M	-	-	-	-	-	-	-	-
Shares	33.2 M	32.3 M	25 M	21.7 M	-	-	-	-	-	-	-	-
Historical Prices	0.65	5.29	19.3	13.3	-	-	-	-	-	-	-	-
Net Income	-67.7 M	-117 M	-49.9 M	-55.6 M	-27.4 M	-16.8 M	-11.4 M	-	-	-	-	-
Revenue	31.9 M	23.7 M	17.4 M	5.78 M	4.75 M	708 K	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-68.3 M	-117 M	-51.3 M	-58.2 M	-27.7 M	-16.5 M	-11.1 M	-	-	-	-	-
Interest Expense	-	-	-	-	-	285 K	261 K	-	-	-	-	-
EBITDA	-66 M	-115 M	-49.2 M	-57.3 M	-27.1 M	-16.2 M	-10.9 M	-	-	-	-	-
Operating Expenses	100 M	140 M	68.8 M	64 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	18.8 M	18.3 M	16.2 M	22.4 M	6.11 M	3.61 M	3.37 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Harpoon Therapeutics

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	3.95 M	37.7 M	37 M	3.58 M	3.31 M	33 M	32.9 M	32.8 M	32.6 M	32.5 M	31.6 M	25.3 M	25.1 M	25 M	24.8 M	24.6 M	24.5 M	24.3 M	13.5 M	1.19 M	1.08 M	1.02 M	969 K	938 K	913 K	886 K	841 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-1.8 M	1.06 M	-11.3 M	-	-11.6 M	-17.4 M	-20.3 M	-	-16.7 M	-16.8 M	-61.7 M	-11.4 M	-13.3 M	-12.7 M	-12.6 M	-14.3 M	-15.9 M	-11.8 M	-13.6 M	-9.73 M	-6.76 M	-5.99 M	-4.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	4.45 M	20.2 M	8.58 M	-	13.6 M	8.3 M	5.91 M	-	4.48 M	14.2 K	9.01 M	7.49 M	3.89 M	2.76 M	3.3 M	2.23 M	1.42 M	1.06 M	1.06 M	1.06 M	1.06 M	1.06 M	1.56 M	708 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-12.1 M	2.49 M	-10.8 M	-	-11.9 M	-17.4 M	-20.3 M	-	-16.7 M	-16.8 M	-61.8 M	-11.5 M	-13.6 M	-13.1 M	-13.1 M	-14.8 M	-16.6 M	-12.6 M	-14.2 M	-9.87 M	-6.85 M	-6.06 M	-4.95 M	-5 M	-4.89 M	-3.65 M	-3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.05 M	1.56 M	138 K	-	-	-	-	-	-	-	-	-11 K	-14 K	-	-1 K	4 K	-26 K	-15 K	-4 K	-8 K	-22 K	-5 K	-2 K	-	-	112 K	173 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-11.9 M	2.89 M	-10.1 M	-	-11.4 M	-16.8 M	-19.7 M	-	-15 M	-15.7 M	-61.2 M	-11.5 M	-12 M	-12.1 M	-12.6 M	-14.8 M	-16.2 M	-12 M	-13.9 M	-9.87 M	-6.4 M	-5.77 M	-4.82 M	-5 M	-4.89 M	-3.65 M	-3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	16.6 M	17.7 M	19.3 M	-	25.5 M	25.7 M	26.2 M	-	21.2 M	22.6 M	70.8 M	19 M	17.5 M	15.9 M	16.4 M	17 M	18 M	13.7 M	15.2 M	10.9 M	7.91 M	7.12 M	6.52 M	5.7 M	4.89 M	3.65 M	3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	4.26 M	3.8 M	4.18 M	-	4.53 M	5.06 M	5.4 M	-	4.19 M	4.34 M	4.6 M	3.92 M	4.43 M	3.94 M	3.91 M	4.33 M	8.49 M	3.73 M	5.83 M	2.22 M	1.94 M	967 K	982 K	912 K	1.01 M	847 K	843 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency